Additionally, ApoC3 levels were, on average, higher in PCOS patients compared to the control group, with an effect size of 0.27 (0.06–0.41), slightly greater than that of ApoA1 (see Table 2). The gene discussed is APOA1; the disease is polycystic ovary syndrome.